<?xml version="1.0" encoding="UTF-8"?>
<p id="p0115">The lack of such diagnostics puts already vulnerable countries at an even higher risk and further strains weak health systems during epi- and pandemics. Investment in smart diagnostics that can be rapidly applied to emerging pathogens on a large scale is needed and needs to be prioritized by stakeholders.</p>
